Number of circulating CD14-positive cells and the serum levels of TNF-α are raised in acute charcot foot

Autor: Afsie Sabokbar, Michael Edmonds, N L Petrova, Guillaume Mabilleau
Přispěvatelé: Groupe d'Études Remodelage Osseux et bioMatériaux (GEROM), Université d'Angers (UA)
Jazyk: angličtina
Rok vydání: 2011
Předmět:
Zdroj: Diabetes Care
Diabetes Care, American Diabetes Association, 2011, 34, pp.e33. ⟨10.2337/dc10-1695⟩
ISSN: 0149-5992
DOI: 10.2337/dc10-1695⟩
Popis: Charcot neuro-osteoarthropathy (CNO) is a devastating complication of diabetes characterized by increased local bone resorption mediated by osteoclasts. Often CNO leads to multiple fractures and joint destruction resulting in severe deformity of the foot. Osteoclasts are multinucleated cells that have a common precursor with monocytes/macrophages (1). Previously, we reported that the number of osteoclasts generated in vitro from circulating cells was higher in acute CNO patients compared with diabetic control subjects and was partially independent from receptor activator for NF-κB (RANK)-RANK ligand (RANKL), the main osteoclastogenic mediator (2). One hypothesis could be that the number of circulating osteoclast precursors is increased in CNO. Among all monocytes subpopulations, CD14-positive cells are the most potent to transform into bone-resorbing osteoclasts (3). We studied 11 diabetic patients with recent onset of acute CNO, 10 diabetic …
Databáze: OpenAIRE